| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.182 | 17.382 | 20.783 | 23.417 | 25.850 | 17.575 | 19.406 | 21.302 | 20.267 | 15.932 |
| Total Income - EUR | 12.182 | 17.382 | 20.794 | 23.417 | 25.850 | 17.575 | 19.406 | 21.302 | 20.267 | 15.932 |
| Total Expenses - EUR | 6.221 | 6.257 | 10.206 | 11.191 | 12.984 | 11.166 | 12.823 | 15.117 | 14.774 | 15.555 |
| Gross Profit/Loss - EUR | 5.962 | 11.125 | 10.588 | 12.225 | 12.866 | 6.408 | 6.583 | 6.185 | 5.493 | 377 |
| Net Profit/Loss - EUR | 5.596 | 10.604 | 10.160 | 11.991 | 12.608 | 6.245 | 6.393 | 5.989 | 5.314 | -30 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pediamed Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 8.546 | 10.903 | 21.107 | 30.040 | 19.066 | 10.446 | 6.997 | 7.096 | 7.432 | 4.915 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 144 | 100 | 99 | 443 | 0 | 0 | 0 | 81 | 1 | 90 |
| Cash | 8.402 | 10.802 | 21.009 | 29.597 | 19.066 | 10.446 | 6.997 | 7.015 | 7.430 | 4.824 |
| Shareholders Funds | 8.523 | 10.657 | 20.637 | 29.561 | 18.416 | 9.841 | 6.441 | 6.473 | 6.714 | 4.133 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 236 | 323 | 470 | 479 | 680 | 606 | 556 | 623 | 718 | 798 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pediamed Consult Srl